-transparent.png){kind=logo}
This article reviews all available studies on the cardiovascular effects of tri- and tetracyclic antidepressants at therapeutic and toxic levels. There is growing evidence that tricyclics, even at therapeutic levels, can be cardiotoxic. Plasma TCA levels are too variable to define a safe therapeutic range. Any patient showing cardiovascular side effects should have an ECG before continuing medication.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
C Bilgi, and
R Campbell
January 1978,
JAMA,
C Bilgi, and
R Campbell
June 1982,
Arizona medicine,
C Bilgi, and
R Campbell
September 1982,
The New England journal of medicine,
C Bilgi, and
R Campbell
December 1986,
IMJ. Illinois medical journal,
C Bilgi, and
R Campbell
January 1984,
Annual review of medicine,
C Bilgi, and
R Campbell
August 1985,
Harefuah,
C Bilgi, and
R Campbell
May 1985,
Archives of neurology,
C Bilgi, and
R Campbell
September 1997,
Neuroscience research,
C Bilgi, and
R Campbell
May 1973,
Activitas nervosa superior,
C Bilgi, and
R Campbell
June 1974,
Acta medica Scandinavica,
